FGF7 has a potent ability to stimulate growth of intestinal epithelial and crypt cells [2–9] and is used as an anti-mucositis conditioning agent to thicken the mucosal lining prior to cancer radiation therapy. The gene discussed is FGF7; the disease is mucositis.